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A 2- to 3-fold increase of GTP cyclohydrolase I (E.C. 3.5.4.16). the key enzyme of tetrahydrobiopterin biosynthesis from GTP, was observed in 
cerebellum, remaining brain, liver, spleen, and adrenal gland of rats treated with a single dose of lipopolysaccha~de (LPS). This led to increased 
biopte~n levels in tissues but not in plasma. Parallel induction of nitric oxide (NO) synthase was indicated by a IO- to I~-fold increase of plasma 
nitrate levels 6 and 12 hours after injection of LPS. Furthe~ore, systolic blood pressure was reduced significantly by 23%. Our results demonstrate 
induction of tetrahydrobiopterin biosynthesis after LPS treatment in vivo. 
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1. INTRODUCTION 
Three enzymes are involved in biosynthesis of 
tetrahydrobiopterin from GTP, i.e. GTP cyclohydro- 
lase I (EC 3.5.4.16), 6-pyruvoyl tetrahydropterin syn- 
thase, and sepiapterin reductase (EC 1 .l .1.153) [l]. In 
human cells in vitro, an up to lOO-fold stimulation of 
GTP ~yclohydrolase I has been observed upon treat- 
ment with cytokines such as interferon-~ or tumour 
necrosis factor-a in a variety of cell types, including 
macrophages, dermal fibroblasts and tumour lines from 
different organs, and the virus-transformed T-cell line 
MT-2 (for review see [2]). Lipopolysaccharide (LPS) 
acts as a costimulator of interferon-y but also exerts 
induction of GTP cyclohydrolase I as a single stimulus 
in macrophages and in endothelial cells [2,3]. In cells of 
rodent origin, cytokine-induced stimulation of GTP cy- 
clohydrolase I was also seen in murine macrophages, 
which already express high enzyme activity when un- 
stimulated, and in murine dermal fibroblasts [2,4]. As 
a result, intracellular tetrahydrobiopterin levels are in- 
creased in human and murine cells after cytokine or 
LPS treatment 1241. Increase in intracellular tetrahy- 
drobiopterin levels upon cytokine or LPS treatment was 
recently also reported for rat vascular smooth muscle 
cells [5]. 
In humans, cytokine-induced stimulation of GTP cy- 
clohydrolase I can be easily detected in vivo by measur- 
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ing neopterin in body fluids. Neopterin is cleaved from 
the first intermediate of tetrahydrobiopterin synthesis, 
i.e. 7,8-dihydroneopterin triphosphate, by phos- 
phatases. 7,8-Dihydroneopterin triphosphate accumu- 
lates in human but not in murine cells due to the com- 
paratively low 6-pyruvoyl tetrahydropterin synthase ac- 
tivity found in human cells [4,6], thus explaining excre- 
tion of neopterin in humans but not in rodents [7]. 
Among human cells, the ratio of GTP ~yclohydrolase 
I to 6-pyruvoyl tetrahydropterin synthase after cytokine 
treatment is highest in macrophages which leads to pro- 
duction of an about 50-fold excess of neopterin over 
biopterin [6,8]. Determination of neopterin in body 
fluids of humans has turned out to be a valuable marker 
for monitoring the immune status in patients suffering 
from diseases which involve activation of cell-mediated 
immunity (for review see [9]). Excretion of biopterin was 
only slightly elevated under these conditions [lo]. 
In contrast to humans, in vivo induction of GTP 
cyclohydrolase I in the course of immune activation has 
thus far not been reported for rodents. However, the 
observation of a 2-fold increase of urinary biopterin 
excretion in tumour-bearing rats fl I] suggests that 
mechanisms imilar to humans also operate in rodents. 
We therefore were interested whether pteridine synthe- 
sis is induced in vivo in rodents challenged with an 
immune stimulus such as LPS. 
Under these conditions, widespread induction of ni- 
tric oxide (NO) synthase, an enzyme which requires 
tetrahydrobiopterin for full activity (reviewed in [ 12]), 
is well documented [13-151. Here, we report that LPS 
increases GTP cyclohydrolase I activities and tetrahy- 
drobiopterin levels in various tissues of rats which is 
paralleled by highly elevated plasma nitrate levels and 
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a drop in systolic blood pressure but no increase of 
plasma biopterin concentrations. 
2. MATERIALS AND METHODS 
2.1. Treatment of rats and preparation of tissue homogenates and 
plasma 
Male Sprague-Dawley rats (200-250 g, Himberg, Austria), fed ad 
libitum, were treated with 6 mg/kg of LPS (phenolic extract from 
~sc~erichia co& 055 : BS, Sigma, Munich, Ge~any) or vehicle (pyro- 
gen-free phosphate-buffered saline, pH 7.4, containing 130 mM NaCl, 
2 mM KCl, 6 mM Na*HPO,, and 1 mM KH,PO,) by intraperitoneal 
injection. In some experiments, ystolic blood pressure was measured 
plethysmographically at the tail of restrained animals with an Infra- 
ton-Tensiomat (Boucke, Tiibingen, Germany) between 6 and 7 h after 
injection of LPS. Tissues were removed after decapitation 7 and 12 h 
after LPS injection. Plasma was obtained by centrifugation of hepar- 
inized (50 IE/ml heparin, Novo Industrials, Bagsvaerd, Denmark) 
blood. Tissues were immediately homogenized in 5 ml 0.1 M Tris-HCl 
buffer, pH 7.8, containing 5 mM EDTA, 0.3 M KCI, 10% (v/v) glyc- 
erol, 100 .uM phenylmethanesulphonyl fluoride (Serva, Heidelberg, 
Germany), and 5 mM 1,Cdithioerythritol (Merck, Darmstadt, Ger- 
many), using an Ultraturrax. Homogenates were then centrifuged for 
5 min at 10,000 x g and the supernatants were used for further assays. 
2.2. Pteridine determination 
Homogenates or plasma were immediately treated with iodine in 
acidic or basic media according to Fukushima and Nixon [16]. Briefly, 
500 ~1 of homogenate or plasma were mixed with 50 ~11 N HCI (total 
biopterin) or 50~1 1 N NaOH (alkali-stable 7,8-dihydrobiopterin and 
fully oxidized biopterin) and 50 ~1 0.1 M iodine in 0.25 M potassium 
iodide. Mixtures were incubated at room temperature in the dark for 
1 h. Alkaline incubations were acidified with lOO@ 1 N HCl. Insoluble 
material from alkaline and acidic incubations was removed by centrif- 
ugation at 10,000 x g for 2 min and excess iodine was reduced by 50 
,& of 0.1 M ascorbic acid. Incubations were applied to solid phase 
cartridges (SCX, Varian, Palo Alto, CA, USA) and then directly 
eluted onto a reversed phase C-18 column (Lichrospher, 250 mm x 4 
mm id., 5 ,um particle size, Merck) using an AASP module (Varian) 
as described [17]. After elution with 0.015 M potassium phosphate 
buffer, pH 6.0, at a Aow rate of 0.8 ml/min, pteridines were detected 
by fluorescence (ex~tation 350 nm, emission 440 nm). 
2.3. Determination of GTP cyclohydrolase I 
GTP cyclohydrolase I activity was quantified by a method modified 
from Viveros et al. [lS] as previously described [6]. Freshly prepared 
homogenates were freed from low mol~ular mass compounds by 
Sephadex G-25 separation (NAP-5 Pharmacia, Uppsala, Sweden). 
The protein fraction was eluted with 0.1 M Tris-HCl, pH 7.8, 5 mM 
EDTA, 0.3 M KCl, 10% (v/v) glycerol, 100 PM phenylmethanesul- 
fonyl fluoride, and 5 mM 1,4_dithioerythritol. Eluates were kept on 
ice until assayed for GTP ~y~lohydrolase I within 4 h of preparation. 
Briefly, 250 ~1 of protein fractions were mixed with 2 mM GTP in a 
final volume of 300 ~1 and incubated for 90 min at 37°C in the dark. 
The reaction was stopped by addition of 0.1 M HCl and 0.01 M I2 
After oxidation of 7,8_dihydroneopterin triphosphate to neopterin 
triphosphate for 1 h at room temperature in the dark, excess iodine 
was reduced with 0.1 M ascorbic acid, in~bations were neutra~~ed 
using 1 N NaOH, and neopterin triphosphate wascleaved to neopterin 
by incubation with alkaline phosphatase (8 U/ml, from calf intestine, 
Serva) for 1 h at 37OC. Neopterin was finally quantified by HPLC as 
outlined above according to a previously described method [17]. Pro- 
tein was dete~ined according to Bradford 1191 (Bio-Rad, Richmond, 
CA, USA) with pure bovine serum albumine (Serva) as a standard. 
2.4. Determination of plasma nitrate levels 
Nitrate in plasma was detected according to Green et al. [20] with 
minor modifications. Briefly, 100 ~1 of plasma were treated with 20 
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~1 of 35% sulfosalicylic acid (Merck), the protein precipitate was 
removed by centrifugation at 10,000 x g for 2 min and the acid was 
neutralized with 1 N NaOH. Samples (50 ~1) were then applied to a 
reversed phase C-18 column (Lichrospher, 250 mm x 4 mm i.d., 5 hum 
particle size, Merck) and eluted with 5% NH&l, pH 7.0. Nitrate was 
reduced to nitrite by a cadmium reactor (cadmium, 0.3-0.8 mm, 20-50 
mesh ASTM, Merck, washed with 0.1 N HCl and packed into a 
Pharmacia HR 5/S glass column), and nitrite was finally quantified 
after post-column mixing with the stable Griess-Ilosvay reagent from 
Merck by measurement of UV absorption at 546 nm. 
3. RESULTS AND DISCUSSION 
Table I shows GTP cyclohydrolase I activities and 
biopterin levels found in tissues of rats either untreated 
or treated with LPS for 7 and 12 h, respectively. For 
untreated animals, highest GTP cyclohydrolase I activ- 
ities were found in liver, spleen, and adrenal gland, and 
activities detected here are within the same order of 
magnitude as was reported for Balblc mice [7]. After 7 
h of LPS treatment, a significant 2-fold increase of GTP 
cyclohydrolase I could be seen only in liver and spleen 
which was not further enhanced after longer LPS treat- 
ment. Increase in activity, however, becomes ignificant 
also in the other tissues tested after 12 h of LPS treat- 
ment, suggesting that induction of GTP cyclohydrolase 
I becomes generalized after longer LPS treatment. 
In parallel, biopterin concentrations are significantly 
increased 2- to 1 O-fold in all tissues but liver. In previous 
work we found that biopterin levels of bile were 30-fold 
higher than biopterin levels from blood of various adja- 
cent blood vessels 1211, suggesting excretion of biopterin 
via bile. This may explain why liver biopterin concen- 
trations were not found to be elevated despite enhanced 
GTP cyclohydrolase I activity. Biopterin levels of adre- 
nal gland were far higher than those obtained with other 
tissues after LPS treatment for 12 h (Table I). The major 
portion of biopterin was found in its tetrahydro-form 
and variation of this amount most probably occurs due 
to instability of tetrahydrobiopterin after homogeniza- 
tion of the tissue. 
In mammals, tetrahydrobiopterin acts as a hydroxyl- 
ation cofactor in monooxygenation of phenylalanine 
[22], tyrosine [23], and tryptophan [24], and in the cleav- 
age of glyceryl ethers in rat liver microsomes 125,267. It 
was further shown to be required for full activity of 
both, cytokine-inducible and constitutive forms of NO 
synthase, an enzyme which further depends on NADPH 
and flavins, and catalyzes the oxygenation of L-arginine 
to NO and r_-citrulline. NO has been shown to be in- 
volved in vasorelaxation, neurotransmission and in 
cytotoxicity (for review see [12]). Using intact cells, it 
has been demonstrated that intracellular tetrahydrobi- 
opterin levels modulate the amount of NO formed in 
murine fibroblasts [27], endothelial and smooth muscle 
cells [28,5], as well as in porcine and human endothelial 
cells [29,3]. 
As previously reported, an about lo-fold increase in 
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urinary nitrate excretion has been observed in rats 
treated with LPS from Escherichia coli within 24 h after 
injection [30]. Further, induction of NO synthase in rats 
has been demonstrated for various tissues 6 h after LPS 
injection, yielding highest activities in lung, liver and 
spleen [ 13,151. As can be seen from Table II, a lo- and 
lOO-fold raise in plasma nitrate levels 7 h and 12 h after 
injection of LPS was observed in our experiments, indi- 
cating induction of NO synthase. In parallel, systolic 
blood pressure was reduced from 137&8 mm Hg (un- 
treated controls) to 106% mm Hg (mean of 5 animals 
rt SD., P < 0.0001, Student’s t-test) as determined 6 h 
after LPS injection. This is consistent with the observa- 
tion, that induction of NO synthase is involved in hypo- 
tension induced by LPS, tumour necrosis factor-a, and 
interleukin-l-a [31-331. 
Interestingly, biopterin concentrations of plasma 
were not significantly increased after 7 h or 12 h of LPS 
treatment (Table II), suggesting that tetrahydrobiop- 
terin is kept effectively within the tissues. This may 
explain why biopterin levels, which are strongly in- 
creased by cytokines in human cells in vitro [2,3,8], are 
only slightly increased in body fluids of patients with 
activated cellular immunity in vivo [lo]. 
Our data clearly demonstrate that treatment with 
LPS, which may act directly but also by induction of 
interferon-~ and tumour necrosis factor-a 1341, leads to 
increased activity of GTP cyclohydrolase I and there- 
fore to increased tetrahydrobiopterin levels in various 
tissues. A similar increase has been reported previously 
for adrenal gland from rats treated with insulin and 
reserpine [18,35]. Inhibition of the effects of insulin and 
reserpine by cycloheximide suggested e novo synthesis 
of GTP cyclohydrolase I in this case [18,35]. In hepato- 
cytes obtained from rats treated with C~rynebacter~~m 
~a~v~rn a 2-fold increase of GTP cyclohydrolase I 
mRNA has been reported 1361, thus indicating that also 
induction of GTP cyclohydrolase I by LPS may be reg- 
ulated by protein de novo synthesis. It was suggested 
previously that increased tetrahydrobiopterin tissue lev- 
els may participate in the regulation of tyrosine hydrox- 
ylase and also tryptophan and phenylalanine hydrox- 
ylase, which are not saturated with tetrahydrobiopterin 
under normal conditions [ 18,351. Administration of 
tetrahydrobiopterin increased tyrosine hydroxylation in 
rat striatum in vivo and in a number of in vitro systems 
including striatal synaptosomes and cultured sympa- 
thetic neurons (outlined in [35]). Results indicating that 
also NO synthase is not saturated with tetrahydrobiop- 
terin but can be further stimulated by exogenous addi- 
Remaining brain 
Liver 
Table I 
Induction of GTP cyclohydrolase I and formation of tetrahydrobiopterin i  tissues of LPS-treated rats. 
Tissue LPS Time GTP-CHI 
(pmol~mg~‘~min~‘) 
Total biopterin (pmol.mg-‘) Hi-biopterin (%) 
Cerebellum - 7h 0.024 f 0.005 7.2 + 2.2 71 It27 
+ 7h 0.032 & 0.010 9.3 + 4.5 87zt: 18 
- 12 h 0.030 f 0.011 9.4 + 2.6 48Z!Z 14 
+ 12 h 0.088 f 0.025*** 19.2 t 5.1** 66rt 14 
7h 0.117 f 0.090 12.0 rt 5.2 59 + 26 
+ 7h 0.114 * 0.020 10.0 rt 2.9 75+ 8 
12 h 0.118~0.011 12.3 2 2.5 8l+ 5 
+ 12 h 0.207 2 0.061** 20.5 r 4.7*+ 83k I 
7h 1.520 ? 0.260 63.1 + 30.4 54F 18 
+ 7h 3.351 Zb 1.051** 76.3 + 15.7 592 I 
12 h 1.948 ? 0.576 78.8 + 31.8 94rt 9 
+ 12 h 3.803 + 0.760*** 77.4 + 19.1 s4+ 17 
7h 0.572 f 0.260 47.2 + 28.4 7oi: 8 
+ lh 1.101 + 0.790* 61.2 k 26.0 7o?I 7 
12 h 0.683 f 0.179 42.0 Z!Z 15.3 73+ 17 
+ 12 h 1.135 * 0.441* 84.9 i: 17.5** 73 fr 16 
Adrenal gland 7h 0.535 ? 0.027 29.9 rt Ii .o 824 4 
+ 7h 1.040 + 0.531 43.1 + 14.6 68 + 29 
12 h 0.688 + 0.179 19.9 * 9.1 49 It: 24 
+ 12 h 2.270 + 0.536*** 182.0 Z!X 39.3*** 37 rt 23 
The data are means f S.D. from 5 (7 h) or 6 (12 h) animals. Rats were treated with vehicle (phosphate-buffered saline) or 6 mg/ml LPS from 
Escherichia coli for 7 or 12 h. For GTP cyclohydrolase I and biopterin determination see section 2. Activity of GTP cyclohydrolase I is given as 
pmol neopterin formed per mg total protein per min. The percentage of tetrahydrobiopterin (H,-biopterin) was calculated from the difference of 
total and alkali-stable 7,8-dihydro and oxidized biopterin. *P c 0.05, **P < 0.01, ***P < 0.001; significantly different from vehicle-treated rats 
(Student’s t-test). 
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Table II 
Biopterin and plasma nitrate levels in LPS-treated rats. 
Treatment Total biop- H,-biop- Nitrate Protein 
term terin @mol. 1-l) (g.l_‘) 
(nmol.l-‘) (%) 
Control 7 h 53.1 f 11.0 59rt 6.7 15.7 + 2.7 46.7 rt 6.3 
LPS 7 h 53.7 + 23.1 62 t 20.4 190.1 + 93.4** 46.4 2 10.6 
Control 12 h 56.6 f 21.2 71 f 13 14.3 + 2.6 47.5 rt 5.2 
LPS 12 h 69.3 f 15.1 60 i: 17 1378.5 ?I 416.2*** 46.5 fr 4.6 
The data are means I! SD. from 5 (7 h) or 6 (12 h) animals. Rats were 
treated with vehicle (phosphate-buffered saline) or 6 mg/kg LPS from 
Escherichia coli for 7 or 12 h. Biopterin was detected after oxidation 
with iodine in acidic (total biopterin) or alkaline (7,8-dihydro- and 
oxidized biopterin) media by HPLC with fluorescence detection. The 
percentage of tetrahydrobiopterin (H,-biopterin) was calculated from 
the difference of total and alkali-stable biopterin. Nitrate was detected 
after reduction to nitrite by means of a cadmium reactor by incubation 
with Griess-Ilosvay reagent. **P < 0.01, ***P < 0.001; significantly 
different from vehicle-treated rats (Student’s r-test). 
tion of the cofactor were obtained for cytokine-induci- 
ble NO synthase [5,27,28] as well as for constitutive NO 
synthase from human endothelial cells [3]. Thus, in- 
creased tetrahydrobiopterin levels following LPS treat- 
ment may act on NO formation as well as on biosynthe- 
sis of ~atecholamines and serotonin. It remains to be 
seen whether there is a ranking order in stimulation of 
the various tetrahydrobiopterin-dependent enzymes by 
LPS- or cytokine-induced raise in tetrahydrobiopterin 
and to what relative extent these pathways contribute 
to LPS- and cytokine-mediated effects such as e.g. hy- 
potension [31-331. 
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